In particular, MUC16 levels have a strong association with metastatic disease, whereas MUC5AC has great efficacy in differentiating resectable early-stage PC from healthy controls, with significant sensitivity for disease detection when combined with CA 19-9 and almost 100% specificity [86]. The gene discussed is MUC16; the disease is pachyonychia congenita.